Alan B. Sandler

Companies

• Revolution Medicines (United States)Chief Development Officer Mar 26, 2026 to now¹
• ALX ONCOLOGY HOLDINGS INCChief Medical Officer Nov 19, 2024 to now²
• ALX ONCOLOGY HOLDINGS INCBoard member Aug 7, 2024 to now³
• Elevation Oncology, Inc.Board member Mar 4, 2024 to now⁴
• Mirati Therapeutics, Inc.Chief Medical Officer Nov 8, 2022 to Jan 23, 2024⁵
• Zai Lab LimitedHead of Global Dev., Oncology Jan 4, 2021 to Jun 27, 2022⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• RMRevolution Medicines (United States) RVMD52,868 shares⁷$10.1M at $190.54Sep 16, 2026
• ZLZai Lab Limited ZLAB28,985 shares⁸$687.4K at $23.71Apr 1, 2022
• MTMirati Therapeutics, Inc.0 shares⁹Jan 23, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 16, 2026Sold 336 shares at $199.30 of Revolution Medicines (United States)⁷
• Sep 16, 2026Sold 5 shares at $194.96 of Revolution Medicines (United States)⁷
• Jan 23, 2024Returned to company 17,021 shares of Mirati Therapeutics, Inc.⁹
• Jan 23, 2024Returned to company 52,297 shares of Mirati Therapeutics, Inc.⁹
• Jan 23, 2024Returned to company 10,547 shares of Mirati Therapeutics, Inc.⁹
• Dec 29, 2023Granted 17,021 shares at $58.75 of Mirati Therapeutics, Inc.¹⁰
• Aug 9, 2023Granted 22,297 shares at $37.00 of Mirati Therapeutics, Inc.¹¹
• Nov 7, 2022Granted 40,000 shares of Mirati Therapeutics, Inc.¹²
• Apr 1, 2022Exercised options 1,060 shares of Zai Lab Limited⁸
• Dec 1, 2021Shares withheld for tax 2,075 shares at $71.23 of Zai Lab Limited¹³